Tuesday, April 23, 2024 Apr 23, 2024
61° F Dallas, TX
Advertisement
Healthcare

Alcon Explores $100 Million Fort Worth Expansion

The eye care giant says it is still looking at multiple locations for a "manufacturing footprint project."
|
Image
iStock: Barbara Smyers

Alcon is exploring a 250,000-square-foot $100 million expansion to its Fort Worth operations, according to documents filed with the City of Fort Worth. Alcon reports that the company is still exploring multiple locations.

As first reported by the Fort Worth Star-Telegram, the world’s largest eye care device company has filed plans to expand its campus south of Fort Worth. Records show that the city staff will meet with the company about the potential for the 135-acre site later this month.

According to Alcon, the company is in an exploratory phase on a new manufacturing project, but it has yet to be approved. The company is considering several locations where the company has a manufacturing presence, and no decisions are likely to be made soon.

Alcon responded to questions about the expansion with the following statement: “Alcon, founded in Fort Worth more than 75 years ago, has deep roots in this community. Our Fort Worth campus has continued to expand in step with the growth in our global eye care business. Because we are global and have manufacturing sites around the world, we continually review our manufacturing footprint to optimize efficiency and capabilities. We are currently in an early exploratory phase on another potential manufacturing footprint project but this plan has not been approved. As always, we are considering multiple locations for this work where we have a manufacturing presence. This process is likely to take some time before any decisions can be made.”

Alcon was founded as a pharmacy in Fort Worth in 1945, focusing on ophthalmic products, and was incorporated as a manufacturer in 1947. Innovations like the standard eye drop bottle and other treatments help the company continue to grow, forming a foundation and a surgical division. With sales of $31 million, the company went public in 1971 and was purchased by Switzerland’s Nestlé in 1977.

The company continued to innovate new products, and in 2010, Swiss pharmaceutical giant Novartis bought a majority stake in the company. In 2019, Alcon spun off from Novartis. In recent years, the company has acquired Ivantis and its glaucoma surgery stent for at least $475 million and Aerie Pharmaceuticals for $770 million to grow its ophthalmic assets.

Today, Alcon impacts 260 million people in 140 countries and has 25,000 associates. According to financial statements, Alcon’s sales in the first half of 2023 were $4.7 billion. According to the Star-Telegram, Alcon employs 4,500 people in Fort Worth, making it the eighth largest employer in Tarrant County.

Author

Will Maddox

Will Maddox

View Profile
Will is the senior writer for D CEO magazine and the editor of D CEO Healthcare. He's written about healthcare…

Related Articles

Image
Healthcare

North Texas Healthcare Compensation: Who’s On Top?

Executives at Tenet Healthcare, McKesson Corp., and CHRISTUS Health lead the way.
Image
Healthcare

Convicted Dallas Anesthesiologist Could Face 190 Years for ‘Toxic Cocktails’ in IV Bags

Dr. Raynaldo Ortiz worked at the Baylor Scott & White Health facility after spending time in jail for shooting a dog and previous Texas Medical Board discipline.
Image
Ask the Expert

I’m Considering A Tummy Tuck. What Do I Need To Know?

Renowned surgeon Steven J. White offers advice for patients seeking this popular option.
Advertisement